Literature DB >> 18784480

Hyperglycaemia and neurological injury.

Amit Prakash1, Basil F Matta.   

Abstract

PURPOSE OF REVIEW: Clinical and experimental data suggest that hypergylcaemia lowers the ischaemic neuronal threshold and worsens outcome in the presence of neurological injury from trauma, stroke and subarachnoid haemorrhage. This review aims to appraise the evidence for tight glycaemic control in patients with neurological injury. RECENT
FINDINGS: Hyperglycaemia can adversely affect outcome in critically ill patients. Intensive insulin therapy with tight glycaemic control has been advocated for improving outcome in these patients. However, the extent to which intensive insulin therapy and tight control of blood glucose improve outcome after ischaemic neurological insults remains unclear. The benefit of such treatment regimes may be negated by the increased frequency of hypoglycaemic episodes, which may aggravate neurological injury. Although it seems sensible to control hyperglycaemia in patients with neurological injury, the treatment must account for potential hypoglycaemic episodes.
SUMMARY: Clinical and experimental data suggest that hyperglycaemia lowers the ischaemic neuronal threshold in the presence of neurological injury. Tight glycaemic control may result in hypoglycaemia, which in itself can be detrimental. Therefore, it seems sensible that we should accept slightly less tight blood glucose control than in the critically ill patient without neurological injury.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18784480     DOI: 10.1097/ACO.0b013e32830f44e4

Source DB:  PubMed          Journal:  Curr Opin Anaesthesiol        ISSN: 0952-7907            Impact factor:   2.706


  13 in total

Review 1.  AKR1B1 Upregulation Contributes to Neuroinflammation and Astrocytes Proliferation by Regulating the Energy Metabolism in Rat Spinal Cord Injury.

Authors:  Xiaoqing Chen; Cheng Chen; Jie Hao; Rongqing Qin; Baiyu Qian; Kai Yang; Jiyun Zhang; Feng Zhang
Journal:  Neurochem Res       Date:  2018-06-12       Impact factor: 3.996

Review 2.  A review of perioperative glucose control in the neurosurgical population.

Authors:  Joshua H Atkins; David S Smith
Journal:  J Diabetes Sci Technol       Date:  2009-11-01

Review 3.  Hyperglycemia in critical illness: a review.

Authors:  David Brealey; Mervyn Singer
Journal:  J Diabetes Sci Technol       Date:  2009-11-01

Review 4.  Translational strategies for neuroprotection in ischemic stroke--focusing on acid-sensing ion channel 1a.

Authors:  Zaven O'Bryant; Kiara T Vann; Zhi-Gang Xiong
Journal:  Transl Stroke Res       Date:  2014-01-05       Impact factor: 6.829

Review 5.  Treating hyperglycemia in neurocritical patients: benefits and perils.

Authors:  Daniel A Godoy; Mario Di Napoli; Alejandro A Rabinstein
Journal:  Neurocrit Care       Date:  2010-12       Impact factor: 3.210

6.  Post-cardiac arrest syndrome: update on brain injury management and prognostication.

Authors:  Navaz Karanjia; Romergryko G Geocadin
Journal:  Curr Treat Options Neurol       Date:  2011-04       Impact factor: 3.598

7.  Incretin mimetics as pharmacologic tools to elucidate and as a new drug strategy to treat traumatic brain injury.

Authors:  Nigel H Greig; David Tweedie; Lital Rachmany; Yazhou Li; Vardit Rubovitch; Shaul Schreiber; Yung-Hsiao Chiang; Barry J Hoffer; Jonathan Miller; Debomoy K Lahiri; Kumar Sambamurti; Robert E Becker; Chaim G Pick
Journal:  Alzheimers Dement       Date:  2014-02       Impact factor: 21.566

Review 8.  Hitting a moving target: Basic mechanisms of recovery from acquired developmental brain injury.

Authors:  Christopher C Giza; Bryan Kolb; Neil G Harris; Robert F Asarnow; Mayumi L Prins
Journal:  Dev Neurorehabil       Date:  2009       Impact factor: 2.308

9.  Optimum serum glucose levels for patients with severe traumatic brain injury.

Authors:  Donald W Marion
Journal:  F1000 Med Rep       Date:  2009-05-28

10.  Inpatient hyperglycemia following aneurysmal subarachnoid hemorrhage: relation to cerebral metabolism and outcome.

Authors:  Florian Schlenk; Peter Vajkoczy; Asita Sarrafzadeh
Journal:  Neurocrit Care       Date:  2009-05-06       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.